Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

I. F. Tannock, K C Murphy, George Armitage et al.|Journal of Clinical Oncology|1996

Cited by 1.6k